These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Distinction between antiulcer effect and cytoprotection. Robert A, Lancaster C, Davis JP, Field SO, Nezamis JE. Scand J Gastroenterol Suppl; 1984 Oct; 101():69-73. PubMed ID: 6599540 [Abstract] [Full Text] [Related]
29. The influence of omeprazole on the protective effects of secretagogues against ethanol-induced gastric ulceration in rats. Wong SH, Cho CH, Ogle CW. Eur J Pharmacol; 1987 Sep 23; 141(3):453-9. PubMed ID: 3666038 [Abstract] [Full Text] [Related]
30. Effects of TY-10957, a stable PGI2 derivative, on gastroduodenal lesions and secretory responses in the rat. Okabe S, Takeuchi K, Niida H, Takinami Y. Digestion; 1990 Sep 23; 45(2):61-71. PubMed ID: 2112498 [Abstract] [Full Text] [Related]
38. Effect of oral and intravenous 16,16-dimethyl prostaglandin E2 in duodenal ulcer and Zollinger-Ellison syndrome patients. Ippoliti AF, Isenberg JI, Hagie L. Gastroenterology; 1981 Jan 23; 80(1):55-9. PubMed ID: 7450412 [Abstract] [Full Text] [Related]
40. Effects of 16,16-dimethyl-PGE2-methyl ester on aspirin- and indomethacin-induced gastric and intestinal lesions in mini pigs. Tabata K, Okabe S. Digestion; 1983 Jan 23; 26(2):61-6. PubMed ID: 6840406 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]